Renal Anemia in Chronic Kidney Disease Non-Dialysis | Chart Trends | US | 2014

This report leverages physician insights as well as patient chart data to provide the most up-to-date information about chronic kidney disease non-dialysis (CKD-ND) patient care in the US, including referral patterns, patient demographics, the use of laboratory assessments, and the use of medications. In particular, our in-depth analysis of CKD-ND medications spans a wide range of variables including product initiation, dosing, switching, and crossovers; coverage has also been expanded in 2014 to include not only erythropoiesis stimulating agents (ESAs), IV and oral iron, but also phosphate binders, vitamin D, calcimimetic, diabetic agents, as well as a new section on products in development for renal anemia. Finally, by comparing what nephrologists report about patient care to actual patient records, gaps in intended versus actual care are uncovered and opportunities for the expanded use of CKD-ND treatments become more clearly defined.

launch Related Market Assessment Reports